Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy

Table 2 Results of genotyping of nucleotide haplotypes obtained in each patient, extracted by next-generation sequencing based on ultra-deep pyrosequencing analysis %

Patient	A	B	C	D	E	F	H
1	0	0	0	0	100	0	0
2	0	0	100	0	0	0	0
3	7.1	0	0	92.9	0	0	0
4	0	0	0	100	0	0	0
5	0	0	0	100	0	0	0
6	1.7	0	0	98.3	0	0	0
7	0	0	0.3	51.3	0	48.4	0
8	7.1	0	0	92.9	0	0	0
9	0	0	0.3	7	0	92.7	0
10	0.9	0	0	50.9	0	0	48.2
11	0	0	0.3	7	0	92.7	0
12	95.1	0	4.4	0.5	0	0	0
13	0	0	100	0	0	0	0
14	46.6	0	8.2	33.2	0	12	0
15	89.7	0	4.4	8	0	1.5	0
16	0	0	0	100	0	0	0
17	0	0	0	100	0	0	0
18	0	0	0	0	100	0	0
19	0	0	95.3	3,6	0.9	0	0
20	100	0	0	0	0	0	0
21	0	99.6	0.4	0	0	0	0
22	0	0	100	0	0	0	0
23	0	0	87.8	12.2	0	0	0
24	0	0	100	0	0	0	0
25	97.9	0	0	2.1	0	0	0
26	0	0	100	0	0	0	0
27	0	0	0	100	0	0	0

%A to %H indicates the percentage of nucleotide haplotypes from each patient, classified as HBV genotype A, B, C, D, E, F or H. HBV: Hepatitis B virus.